Agilent Technologies (NYSE:A) Releases Q2 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its second quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of 1.250-1.280 for the period, compared to the consensus EPS estimate of 1.310. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Wall Street Analyst Weigh In

Several analysts have weighed in on A shares. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $135.00 to $145.00 in a report on Monday, February 10th. Sanford C. Bernstein lowered their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Robert W. Baird cut their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Finally, Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Trading Down 4.4 %

Shares of NYSE:A traded down $5.91 on Thursday, reaching $128.56. 860,993 shares of the company traded hands, compared to its average volume of 1,652,657. Agilent Technologies has a 52 week low of $124.16 and a 52 week high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The business’s 50-day simple moving average is $140.90 and its 200 day simple moving average is $139.28. The stock has a market capitalization of $36.68 billion, a P/E ratio of 29.12, a price-to-earnings-growth ratio of 3.63 and a beta of 1.07.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. As a group, equities analysts anticipate that Agilent Technologies will post 5.56 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.